Macular peeling-induced retinal damage: clinical and histopathological evaluation after using different dyes
- PMID: 29948176
- DOI: 10.1007/s00417-018-4029-2
Macular peeling-induced retinal damage: clinical and histopathological evaluation after using different dyes
Abstract
Purpose: To describe functional and histopathological findings after macular peeling using different dyes.
Methods: Prospective, randomized, comparative, interventional, and immunohistochemical study. Forty-five eyes from 45 patients with idiopathic epiretinal membrane (ERM) underwent pars plana chromovitrectomy with ERM and inner limiting membrane (ILM) using trypan blue 0.15% + brilliant blue 0.05% + lutein 2% in group 1 (15 eyes), trypan blue 0.15% + brilliant blue 0.025% + polyethylene glycol 3350 4% in group 2 (15 eyes), and indocyanine green 0.05% in group 3 (15 eyes). We evaluated visual acuity (VA) and macular sensitivity (MS) preoperatively, 1, 3, and 6 months after surgery. The expression of glial fibrillary acidic protein (GFAP) and neurofilament protein (NF) was assessed immunohistochemically on the ILMs peeled as markers of glial and neuronal cells.
Results: In group 1, both mean VA and MS were significantly better at 1 and 3 months after surgery (P < 0.05), whereas no significant difference was found after 6 months. GFAP and NF expression was significantly lower in group 1 (P < 0.05).
Conclusions: The ERM/ILM peeling is thought to rip off the intraretinal tissue, based on the amounts of GFAP and NF in the specimens. The use of lutein dyes reduces iatrogenic stress to the retinal tissue and allows a faster functional recovery in the first 3 months after surgery, suggesting a less iatrogenic adhesion to the retinal tissue.
Keywords: Dye; Epiretinal membrane; Glial fibrillary acidic protein; Macular peeling; Müller cells; Neurofilament protein; Pars plana vitrectomy.
Similar articles
-
Does the presence of an epiretinal membrane alter the cleavage plane during internal limiting membrane peeling?Ophthalmology. 2010 Feb;117(2):320-3.e1. doi: 10.1016/j.ophtha.2009.07.024. Epub 2009 Dec 14. Ophthalmology. 2010. PMID: 20006906
-
Double staining with brilliant blue G and double peeling for epiretinal membranes.Ophthalmology. 2009 Jul;116(7):1370-6. doi: 10.1016/j.ophtha.2009.01.024. Epub 2009 May 8. Ophthalmology. 2009. PMID: 19427701
-
Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair.Ophthalmology. 2004 Dec;111(12):2246-53. doi: 10.1016/j.ophtha.2004.05.037. Ophthalmology. 2004. PMID: 15582081
-
THE EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON IDIOPATHIC EPIRETINAL MEMBRANE SURGERY, WITH A REVIEW OF THE LITERATURE.Retina. 2017 May;37(5):873-880. doi: 10.1097/IAE.0000000000001263. Retina. 2017. PMID: 27617536 Review.
-
Current concepts of trypan blue in chromovitrectomy.Dev Ophthalmol. 2008;42:91-100. doi: 10.1159/000138980. Dev Ophthalmol. 2008. PMID: 18535383 Review.
Cited by
-
Membrane Blue Dual Protects Retinal Pigment Epithelium Cells/Ganglion Cells-Like through Modulation of Mitochondria Function.Biomedicines. 2022 Nov 8;10(11):2854. doi: 10.3390/biomedicines10112854. Biomedicines. 2022. PMID: 36359372 Free PMC article.
-
Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.Ophthalmologica. 2021;244(5):418-450. doi: 10.1159/000515148. Epub 2021 Feb 10. Ophthalmologica. 2021. PMID: 33567434 Free PMC article. Review.
-
Biomechanical properties of retina and choroid: a comprehensive review of techniques and translational relevance.Eye (Lond). 2021 Jul;35(7):1818-1832. doi: 10.1038/s41433-021-01437-w. Epub 2021 Mar 1. Eye (Lond). 2021. PMID: 33649576 Free PMC article. Review.
-
Retinal and Corneal Changes Associated with Intraocular Silicone Oil Tamponade.J Clin Med. 2022 Sep 5;11(17):5234. doi: 10.3390/jcm11175234. J Clin Med. 2022. PMID: 36079165 Free PMC article. Review.
-
A randomised controlled trial evaluating internal limiting membrane peeling forceps in macular hole surgery.Graefes Arch Clin Exp Ophthalmol. 2023 Jun;261(6):1553-1562. doi: 10.1007/s00417-022-05932-y. Epub 2022 Dec 13. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 36512088 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous